BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1601359)

  • 21. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
    Fuster V; Falk E; Fallon JT; Badimon L; Chesebro JH; Badimon JJ
    Thromb Haemost; 1995 Jul; 74(1):552-9. PubMed ID: 8578523
    [No Abstract]   [Full Text] [Related]  

  • 23. [Restenosis after percutaneous transluminal coronary angioplasty].
    Aschermann M
    Cas Lek Cesk; 1990 Apr; 129(17):513-5. PubMed ID: 2350767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mechanisms of re-stenosis after angioplasty].
    Bauriedel G; Kandolf R; Welsch U; Höfling B
    Z Kardiol; 1994; 83 Suppl 4():31-41. PubMed ID: 7856278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells].
    Voisard R; Dartsch PC; Seitzer U; Grupp C; Hannekum A; Kochs M; Hombach V
    Vasa Suppl; 1991; 33():138-9. PubMed ID: 1788646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormone therapy as a therapeutic option in prevention of restenosis after angioplasty? Analysis of estrogen and progesterone receptors in human coronary plaque cells in vitro].
    Voisard R; Seitzer U; Hannekum A; Kochs M; Hombach V; Böhm W
    Vasa Suppl; 1992; 35():130-1. PubMed ID: 1481016
    [No Abstract]   [Full Text] [Related]  

  • 27. [Restenosis after percutaneous coronary angioplasty--cause, prevention strategies].
    Szyguła J; Puzio B; Poloński L
    Wiad Lek; 1998; 51(1-2):76-81. PubMed ID: 9608836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study].
    Inoue K; Nakamura N; Kakio T; Suyama H; Tanaka S; Goto Y; Nakazawa Y; Yamamoto Y; Nagamatsu T
    J Cardiol; 1994; 24(4):279-91. PubMed ID: 8057240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogenic activity in connection with coronary angioplasty.
    Johansson SR; Nilsson J; Hamsten A; Emanuelsson H
    Eur Heart J; 1993 Jul; 14(7):904-9. PubMed ID: 8375413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing restenosis after coronary angioplasty.
    Popma JJ; Topol EJ
    Am J Med; 1990 Jan; 88(1N):16N-24N. PubMed ID: 2195881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biological and cellular mechanisms of restenosis after transluminal coronary angioplasty].
    De Caterina R; Marzilli M
    G Ital Cardiol; 1991 Jan; 21(1):75-86. PubMed ID: 2055380
    [No Abstract]   [Full Text] [Related]  

  • 33. [Restenosed growth of plaque cells from restenosed peripheral and coronary plaque material of the human in vitro: a correlation to animal experiment results following angioplasty].
    Voisard R; Dartsch PC; Seitzer U; Hannekum A; Hombach V; Betz E
    Vasa Suppl; 1991; 33():135-7. PubMed ID: 1838622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular radiation therapy to reduce coronary artery restenosis.
    Chougule PB
    Surg Oncol Clin N Am; 2000 Jul; 9(3):577-84, x. PubMed ID: 10853143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelial recovery: the next target in restenosis prevention.
    Losordo DW; Isner JM; Diaz-Sandoval LJ
    Circulation; 2003 Jun; 107(21):2635-7. PubMed ID: 12782613
    [No Abstract]   [Full Text] [Related]  

  • 36. [Restenosis: physiopathology, treatments and prevention].
    Lafont A; Durand E; Rahal S; de Oliveira M; Guérin Y; Fernandez F; Desnos M; Guérot C
    Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):349-53. PubMed ID: 8561439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes?
    Lafont A; Libby P
    J Am Coll Cardiol; 1998 Jul; 32(1):283-5. PubMed ID: 9669282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediators of restenosis.
    Kagan SA; Myers SI
    Surg Clin North Am; 1998 Jun; 78(3):481-500. PubMed ID: 9673658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth factors in pathogenesis of coronary arterial restenosis.
    Cercek B; Sharifi B; Barath P; Bailey L; Forrester JS
    Am J Cardiol; 1991 Nov; 68(12):24C-33C. PubMed ID: 1951099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential mechanisms promoting restenosis in diabetic patients.
    Aronson D; Bloomgarden Z; Rayfield EJ
    J Am Coll Cardiol; 1996 Mar; 27(3):528-35. PubMed ID: 8606261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.